Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 2 1

Status

Withdrawn 1Unknown 1Terminated 1Suspended 1

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Classical hematology 4Other hematologic neoplasm 3Thoracic 1Plasma cell 1Myeloid 1Gynecologic 1

Conditions

Anemia 4Uterine Cervical Neoplasms 1Neoplasms 1Myelodysplastic Syndromes 1Leukemia 1Hematologic Neoplasms 1Bone Marrow Failure Disorders 1Anemia, Aplastic 1

Interventions

Cyclophosphamide 93fludarabine phosphate 86Busulfan 63Cyclosporine 57Peripheral Blood Stem Cell Transplantation 54Mycophenolic Acid 54Whole-Body Irradiation 53Epoetin Alfa 53Antilymphocyte Serum 43fludarabine 42Filgrastim 41Cytarabine 41Tacrolimus 39Melphalan 38Darbepoetin alfa 38Methotrexate 34Radiotherapy 32Cord Blood Stem Cell Transplantation 28Granulocyte Colony-Stimulating Factor 23Methylprednisolone 21Etoposide 21apixaban 18eltrombopag 16Thiotepa 16Dalteparin 16ferric carboxymaltose 14Daunorubicin 14Azacitidine 14Alemtuzumab 14thymoglobulin 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Blood Transfusion × Classical hematology × Clear all
NCT03086252 2018-07-26

Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study

Emory University

Phase NA Withdrawn
Classical hematologyMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Anemia, Aplastic, Leukemia, Myelodysplastic Syndromes, Hematologic Neoplasms

NCT01116479 2014-11-05

HaemOPtimal

Rigshospitalet, Denmark

Phase 2 Terminated
180 enrolled
Classical hematology

Anemia, Neoplasms

NCT01648946 2012-11-06

TRICCOP

Instituto do Cancer do Estado de São Paulo

Phase 3 Unknown
300 enrolled
Classical hematology

Anemia

NCT00921635 2009-06-19

HOSTT

Tri-Service General Hospital

Phase 3 Suspended
2 enrolled
Classical hematologyGynecologic

Anemia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡